期刊文献+

烟酰胺单核苷酸对内毒素休克小鼠死亡率的影响

Effect of nicotinamide mononucleotide on mortality of mice with endotoxic shock
下载PDF
导出
摘要 目的探究烟酰胺单核苷酸(NMN)对脂多糖(LPS)诱导的内毒素休克小鼠死亡率的影响。方法将10周龄C57BL/6J雄性小鼠随机分组,均腹腔注射LPS(10 mg/kg)造模。NMN腹腔注射给药,分为3种方式:(1)造模后0.5 h给药,剂量为10、30、100、300 mg/kg;(2)造模前0.5 h给药,剂量为30、100、300、600 mg/kg;(3)造模后0.5 h和12 h两次给药,每次300 mg/kg。观察记录每组小鼠的死亡情况,并绘制生存曲线。结果与溶剂对照组相比,造模后0.5 h或造模前0.5 h给予不同剂量NMN,均不能改善小鼠死亡率或延缓死亡时间;造模后0.5 h和12 h两次给予NMN会加速小鼠死亡,增加小鼠死亡率。两个厂家的NMN产品效果类似。结论NMN对LPS诱导的内毒素休克小鼠不具有治疗作用,小鼠内毒素休克发生后进行NMN多次给药会增加死亡率。 Objective To study the effect of nicotinamide mononucleotide(NMN)on the mortality of the lipopolysaccharide(LPS)-induced endotoxic shock mouse model.Methods 10-week-old C57 BL/6 J male mice were randomly divided into groups,and were injected intraperitoneally(i.p.)with LPS(10 mg/kg)to induce endotoxic shock models.NMN was i.p.injected in three ways:(1)0.5 h after modeling,doses of 10,30,100 and 300 mg/kg;(2)0.5 h before modeling,doses of 30,100,300 and600 mg/kg;or(3)0.5 and 12 h after modeling,dose of 300 mg/kg each time.The death times of each group were recorded,and the survival curves were drawn.Results Compared with the solvent control group,NMN at different doses given 0.5 h after or before modeling didn’t improve the survival rate or delay the death time of endotoxic shock mice;But when given at 0.5 and 12 h300 mg/kg after modeling,NMN accelerated the death of mice and increased the mortality of mice.NMN products by two manufacturers showed similar effects.Conclusion NMN has no therapeutic effect on LPS-induced endotoxic shock,and repeated administration of NMN after endotoxic shock will increase the mortality.
作者 汪东昇 郑斯莉 程明和 缪朝玉 WANG Dongsheng;ZHENG Sili;CHENG Minghe;MIAO Chaoyu(Department of Pharmacology,Naval Medical University,Shanghai 200433,China)
出处 《药学实践杂志》 CAS 2021年第2期134-137,142,共5页 Journal of Pharmaceutical Practice
基金 上海市科委生物医药领域科技支撑项目(16431901400) 国家自然科学基金重点项目(81730098)。
关键词 烟酰胺单核苷酸 脂多糖 内毒素休克 死亡率 nicotinamide mononucleotide lipopolysaccharide endotoxic shock mortality
  • 相关文献

参考文献4

二级参考文献46

  • 1谭余庆.抗内毒素药物的研究概况[J].广西医学,1996,18(5):542-542. 被引量:4
  • 2[3]Evans ME,Feola D J,J,Rapp R P,et al.Polymyxin B Sulfate and colistion:old antibiotics for emerging muhiresistant gramnegative bacteria[J].Ann Pharmacother,1999,33(9):960-967.
  • 3[4]Loppnow H,Libby P,Freudenberg M,et al.Cytokine induction by lipopolysaccharide(LPS)corresponds to lethal toxicitv and is inhibited by nontoxic Rhodobacter capsulatus LPS[J].Infect Immun,1990,58(11):3743-3750.
  • 4[6]Jackman J E,Fierke C A,Tumey L N,et al.Antibacterial agents that target lipid A biosynthesis in Gram-negative bactera[J].JBiol Chem,2000,275(15):11002.
  • 5[7]Steven M,Richard L.Antiendotoxin strategies for the prevention and treatment of septic shock[J].Drugs,1998,55(4):497.
  • 6[8]Danner R L,van Dervort A L,Doerfler M E,et al.Antiendotoxin activity of lipid A analogues:requirement of the chemical structure[J].Pharm Res,1990,7(3):260-263.
  • 7[9]Christ W J,Asano O,Robidoux A L,et al.E5531,A pure endotoxin antagonist of hish potency[J].Science,1995,268(5207):80-83.
  • 8[10]Kawata T,Bristol J R,Rossignol D P,et al.E5531,A synthetic non-toxin lipid A derivate blicks the immunbiological activities of liopolysaccharide[J].Br J Pharmacol,1999,127(4):853-862.
  • 9[11]Kobayashi S.Kawata T,Kimura A,et al.Suppression of murine endotoxion response by E5531,a novel synthetic lipid A antagonist[J].Antimicrob Agents Chemother,1998,42(11):2824-2829.
  • 10[12]Kawata T,Bristol J R,Rossianol D P,et al.E5531,A synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide[J].Br J Pharmacol,1999,127(4):853.

共引文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部